Michelle Bell
About Michelle Bell
Michelle Bell is a Territory Business Manager in Psychiatry at Alkermes, based in Paramus, New Jersey, with extensive experience in pharmaceutical sales and numerous awards for her achievements.
Current Role at Alkermes
Michelle Bell currently serves as the Territory Business Manager for Psychiatry at Alkermes in Paramus, New Jersey. In this role, she provides product education for medications such as Lybalvi and Aristada, which are targeted at treating Bipolar 1 and Schizophrenia.
Previous Experience at Takeda Pharmaceuticals
Michelle Bell worked at Takeda Pharmaceuticals for nearly a decade, starting in 2011. She held various positions including Professional Sales Representative, Senior Professional Sales Representative, Neuroscience Sales Specialist, and Senior Neuroscience Sales Specialist. She provided her expertise in disease states like MDD, ADHD, and Type 2 Diabetes. She was also the District and East Region Neuroscience Training Lead from 2017 to 2019 and the District Business Lead from 2019 to 2020.
Awards and Recognitions
Throughout her career, Michelle Bell has received multiple awards. She earned the 2012 Gold Cresset award, ranking #6 in the region and in the top 10% nationally. She won the 2013 National Gout Franchise contest and received Silver Cresset awards in 2014 and 2015, ranking in the top 7% nationally. At Carr Business Systems, she won the Presidents Club and Rookie of the Year awards in 2009.
Educational Background
Michelle Bell studied at the University of Rhode Island where she achieved a Bachelor's degree in Communicative Disorders. She completed her studies from 2004 to 2007, which laid the foundation for her successful career in pharmaceutical sales and management.
Specializations and Expertise
Michelle Bell specializes in several disease states including Major Depressive Disorder (MDD), Attention Deficit Hyperactivity Disorder (ADHD), Type 2 Diabetes, Acute and Chronic Gout, Gastroesophageal Reflux Disease (GERD), Laryngopharyngeal Reflux (LPR), Chronic Idiopathic Constipation (CIC), Irritable Bowel Syndrome (IBS), Opioid-Induced Constipation (OIC), and Obesity. Her broad expertise makes her a valuable asset in the field of psychiatry and disease management.